Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125939171 | 12593917 | 1 | I | 201605 | 20160520 | 20160726 | 20160726 | PER | US-UNITED THERAPEUTICS-UNT-2016-008314 | UNITED THERAPEUTICS | 63.33 | YR | F | Y | 112.47000 | KG | 20160726 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125939171 | 12593917 | 1 | PS | TYVASO | TREPROSTINIL | 1 | 18-54 MICROGRAMS, QID | 2100758 | 22387 | INHALATION GAS | QID | ||||||||
125939171 | 12593917 | 2 | C | SILDENAFIL. | SILDENAFIL | 1 | 0 | ||||||||||||
125939171 | 12593917 | 3 | C | XARELTO | RIVAROXABAN | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125939171 | 12593917 | 1 | Pulmonary arterial hypertension |
125939171 | 12593917 | 2 | Product used for unknown indication |
125939171 | 12593917 | 3 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125939171 | 12593917 | Chest pain | |
125939171 | 12593917 | Cough | |
125939171 | 12593917 | Dry mouth | |
125939171 | 12593917 | Dysgeusia | |
125939171 | 12593917 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125939171 | 12593917 | 1 | 20160520 | 201605 | 0 |